ANAB Company Profile and Key Details
AnaptysBio, Inc.
ANAB Stock Price Chart
Stock Price Today
AnaptysBio, Inc. (ANAB) stock declined over -4.81%, trading at $12.38 on NASDAQ, down from the previous close of $13.00. The stock opened at $12.99, fluctuating between $12.21 and $12.99 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Company Information
| Employees | 117 |
| Beta | -0.24 |
| Sales or Revenue | $17.16M |
| 5Y Sales Change% | 2.145% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
AnaptysBio, Inc. (NASDAQ: ANAB) stock price is $12.38 in the last trading session. During the trading session, ANAB stock reached the peak price of $12.99 while $12.21 was the lowest point it dropped to. The percentage change in ANAB stock occurred in the recent session was -4.81% while the dollar amount for the price change in ANAB stock was -$0.63.
The NASDAQ listed ANAB is part of Biotechnology industry that operates in the broader Healthcare sector. AnaptysBio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Beth Mueller
Senior Vice President of HR
Dr. Martin Dahl Ph.D.
Senior Vice President of Research
Mr. Eric J. Loumeau
Chief Legal Officer
Mr. Daniel R. Faga
Interim Pres & Chief Executive Officer and Director
Mr. Hamza Suria M.B.A., M.Sc.
Advisory
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.
Chief Medical Officer
Mr. Dennis M. Mulroy
Chief Financial Officer
Mr. Benjamin Stone
Senior Vice President of Corporation Devel.
ANAB's closing price is 1.35% higher than its 52-week low of $12.21 where as its distance from 52-week high of $41.31 is -70.04%.
Number of ANAB employees currently stands at 117.
Official Website of ANAB is: https://www.anaptysbio.com
ANAB could be contacted at phone 858 362 6295 and can also be accessed through its website. ANAB operates from 10770 Wateridge Circle, San Diego, CA 92121-5801, United States.
ANAB stock volume for the day was 431.9K shares. The average number of ANAB shares traded daily for last 3 months was 675.08K.
The market value of ANAB currently stands at $376.56M with its latest stock price at $12.38 and 30.43M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com